Navigation Links
Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share
Date:8/7/2008

products.

Europe and Rest of the World ("ROW") Generic Sales

Sales of European and ROW generic products were $217 million in the second

quarter of 2008, compared to $188 million in the prior year period. This

increase is primarily related to the positive impact of foreign currency

exchange fluctuations compared to the prior year period. Excluding the

impact of foreign currency fluctuations, overall sales were in line with

last year as strong growth in Russia and other Central European markets

offset declines in Croatia and Germany.

Proprietary Product Sales

The Company's proprietary product sales were $118 million for the second quarter of 2008, compared to $102 million in the prior year period. For the first six months of 2008, proprietary product sales were $214 million, compared to $191 million in the prior year period. The increase in proprietary sales for the quarter and the six month period was primarily attributable to increased sales of several products, including SEASONIQUE(R) extended-cycle oral contraceptive and the PARAGARD(R) IUC.

Alliance and Development Revenue

During the second quarter of 2008, the Company reported alliance and development revenue of $93 million, up from $36 million in the prior year period. For the first six months of 2008, alliance and development revenue was $125 million, compared to $61 million in the prior year period. The increase in the quarter and the six month period is primarily related to the $53 million payment made by Allergan to Barr in May 2008 related to Allergan's buy-out of all future financial obligations related to the Sanctura(R) product that PLIVA divested in 2005 to Esprit Pharma, which has since been acquired by Allergan.

Other Revenue

Other revenue primarily includes revenue from the Company's non-core operations, including the diagnostic, disinfectants, dialysis and infusions (DDD&I) business. Other revenue totaled $11
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
2. Caliper Life Sciences Reports Second Quarter 2008 Results
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. EntreMed Reports Second Quarter 2008 Financial Results
5. Transgenomic Reports Second Quarter 2008 Results
6. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
7. Bionovo Reports Second Quarter 2008 Financial Results
8. AtriCure Reports Record Second Quarter 2008 Financial Results
9. AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
10. eResearchTechnology Reports Second Quarter 2008 Results
11. SuperGen Reports 2008 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 The first ... a next generation approach to robotics. What sets Droidles ... patent pending technology that allows them to communicate, share ... wirelessly over the internet. , “The invention is the ... the little Droidles a life of their own, both ...
(Date:7/29/2014)... Eppendorf Centrifuge 5427 R has ... R is geared towards high-end applications like genomic, atomic, ... towards work requiring high sample throughput. Pipette.com is excited ... their extensive 16, 48, and 64 multichannel pipettes as ... tubes, PCR strip tubes, and more. , Introducing ...
(Date:7/29/2014)... The prestigious "Discovery or Exploration in History ... to Juliana Hillis and Kaylie O’Connell, students at Stoneham ... an Egg, Everything: America’s First IVF Baby". This project ... National History Day program during a week-long final competition ... Washington, D.C. , The growing popularity of the assisted ...
(Date:7/29/2014)... Dr. Jason Wendel – recipient of a ... of the Top 10 Plastic Surgeon Specialists for Nashville, TN ... His complete line includes a Hydration Booster, Retexturing Night Crème, ... and skin a younger, more radiant appearance while protecting them ... different, that is why at Dr. J. J. Wendel Plastic ...
Breaking Biology Technology:Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3Dr. J. J. Wendel Launches New Line of Skin Care Products 2
... MONTREAL and KIEL, Germany, ... researchers at the Kiel- based Collagen,Research Institute (CRI) ... peptides (FORTIGEL(R)) in the context of cell experiments.,Last ... the congress of the,Osteoarthritis Research Society International (OARSI) ...
... , BOZEN, Italy, September 14 ... CytoCare(TM) and i.v.STATION(TM) Robots to,be deployed across all of its ... "After multi-year due diligence on 2 ... on this exciting new technology [due to RIVA,s,publicly announced multi-year ...
... , , , ... Inc. (Nasdaq: CALP ), a leading provider of ... today introduced the IVIS Lumina XR in vivo imaging system, ... XR system combines highly sensitive bioluminescence and fluorescence molecular optical ...
Cached Biology Technology:Important Step Forward in Osteoarthritis Research: Bioactive Collagen Peptides Stimulate the Regeneration of Cartilage Tissue 2Important Step Forward in Osteoarthritis Research: Bioactive Collagen Peptides Stimulate the Regeneration of Cartilage Tissue 3Dr M Group Selects Health Robotics' Technology Over RIVA for all of its I.V. Compounding Centers in South East Asia 2Dr M Group Selects Health Robotics' Technology Over RIVA for all of its I.V. Compounding Centers in South East Asia 3Dr M Group Selects Health Robotics' Technology Over RIVA for all of its I.V. Compounding Centers in South East Asia 4Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray 2Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray 3
(Date:7/28/2014)... Food and Drug Administration (FDA) for other purposes can ... human cells, including those that cause Legionnaires, disease, brucellosis, ... mBio , the online open-access journal of the American ... non-antibiotic drugs that could one day help curb bacterial ... list inhibit the growth of at least three of ...
(Date:7/28/2014)... coral communities showing signs of damage from the Deepwater Horizon ... in the Gulf of Mexico. The discovery was made by ... Penn State University. A paper describing this work and additional ... Mexico will be published during the last week of July ... Proceedings of the National Academy of Sciences . , "The ...
(Date:7/28/2014)... the South Pole in 1911, but new research shows ... , Using data from 16 ice cores collected from ... South Pole, a group led by Joe McConnell of ... the most accurate and precise reconstruction to date of ... described in an article published today in the online ...
Breaking Biology News(10 mins):New route to identify drugs that can fight bacterial infections 2Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3
... NOAA scientists report the discovery of the first known colony of ... A report on the discovery was published last month in the ... name due to its flat-topped, table-like shape, table coral ( Acropora ... of the tropical Pacific, but it has never been observed in ...
... online by the Nature journal Leukemia suggests ... some types of leukemia resist treatment can increase the ... Cincinnati Children,s Hospital Medical Center report that their experimental ... along with chemotherapy was particularly effective at stopping ...
... Calif. , Aug. 8, 2013 The radio frequency ... moving slowly mainly due to high costs and the criticality ... related to food safety and drug traceability in the U.S. ... into the market. New analysis from Frost & ...
Cached Biology News:Study suggests way to fight therapy resistant leukemia by blocking DNA repair 2Study suggests way to fight therapy resistant leukemia by blocking DNA repair 3Frost & Sullivan: Government Mandates Create Momentum in Uptake of Radio Frequency Identification in Global Cold Chain 2Frost & Sullivan: Government Mandates Create Momentum in Uptake of Radio Frequency Identification in Global Cold Chain 3Frost & Sullivan: Government Mandates Create Momentum in Uptake of Radio Frequency Identification in Global Cold Chain 4
... Dot Blot Kits overcome this limitation and ... a wide range in low-density protein array ... They are ideal for performing reverse-phase protein ... for the presence of low abundant antigens. ...
AC input: 50-60 Hz 115-120 V...
... is an aqueous solution that contains ... non-toxic stabilizing chemicals in a MES ... 6.5. This product contains a ... bromonitrodioxane as a preservative. StabilZyme ...
... [3D12] to Lambda Free Light Chain ... light chains of human immunoglobulin. ... constantly expressed epitope of lambda chain. ... of free lambda chains but not ...
Biology Products: